148 related articles for article (PubMed ID: 9857872)
1. Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass.
Kimmel SE; Sekeres MA; Berlin JA; Ellison N; DiSesa VJ; Strom BL
J Am Coll Cardiol; 1998 Dec; 32(7):1916-22. PubMed ID: 9857872
[TBL] [Abstract][Full Text] [Related]
2. Mortality and adverse events after protamine administration in patients undergoing cardiopulmonary bypass.
Kimmel SE; Sekeres M; Berlin JA; Ellison N
Anesth Analg; 2002 Jun; 94(6):1402-8, table of contents. PubMed ID: 12031996
[TBL] [Abstract][Full Text] [Related]
3. Adverse events after protamine administration following cardiopulmonary bypass in infants and children.
Seifert HA; Jobes DR; Ten Have T; Kimmel SE; Montenegro LM; Steven JM; Nicolson SC; Strom BL
Anesth Analg; 2003 Aug; 97(2):383-389. PubMed ID: 12873922
[TBL] [Abstract][Full Text] [Related]
4. Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction.
Comunale ME; Maslow A; Robertson LK; Haering JM; Mashikian JS; Lowenstein E
J Cardiothorac Vasc Anesth; 2003 Jun; 17(3):309-13. PubMed ID: 12827577
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of patients at risk for protamine reactions.
Levy JH; Schwieger IM; Zaidan JR; Faraj BA; Weintraub WS
J Thorac Cardiovasc Surg; 1989 Aug; 98(2):200-4. PubMed ID: 2755152
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic changes after protamine administration: association with mortality after coronary artery bypass surgery.
Welsby IJ; Newman MF; Phillips-Bute B; Messier RH; Kakkis ED; Stafford-Smith M
Anesthesiology; 2005 Feb; 102(2):308-14. PubMed ID: 15681944
[TBL] [Abstract][Full Text] [Related]
7. [Anaphylaxis to protamine during cardiovascular surgery].
Madani H; Sadiki EO; Bouziane M; Amaarouch S; Madani M; Khatouf M
Ann Pharm Fr; 2014 May; 72(3):143-5. PubMed ID: 24780829
[TBL] [Abstract][Full Text] [Related]
8. [A case of anaphylactic shock in an elderly man following protamine sulfate administration during emergent off-pump coronary artery bypass grafting].
Kudoh O; Warabi K; Yamaguchi K; Ichinose M; Iizuka T; Inada E
Masui; 2006 May; 55(5):605-10. PubMed ID: 16715917
[TBL] [Abstract][Full Text] [Related]
9. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass.
Olsson A; Alfredsson J; Håkansson E; Svedjeholm R; Berglund J; Berg S
Scand Cardiovasc J; 2016; 50(1):58-63. PubMed ID: 26402229
[TBL] [Abstract][Full Text] [Related]
10. A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.
Pretorius M; Scholl FG; McFarlane JA; Murphey LJ; Brown NJ
Clin Pharmacol Ther; 2005 Nov; 78(5):477-85. PubMed ID: 16321614
[TBL] [Abstract][Full Text] [Related]
11. Life threatening cardiopulmonary failure in an infant following protamine reversal of heparin after cardiopulmonary bypass.
Boigner H; Lechner E; Brock H; Golej J; Trittenwein G
Paediatr Anaesth; 2001 Nov; 11(6):729-32. PubMed ID: 11696152
[TBL] [Abstract][Full Text] [Related]
12. Effect of prostaglandin E1 on pulmonary hypertension after protamine injection during cardiac surgery.
Abe K; Sakakibara T; Miyamoto Y; Ohnishi K
Eur J Clin Pharmacol; 1998 Mar; 54(1):21-5. PubMed ID: 9591925
[TBL] [Abstract][Full Text] [Related]
13. Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent.
Morel DR; Costabella PM; Pittet JF
Anesthesiology; 1990 Sep; 73(3):415-24. PubMed ID: 2098007
[TBL] [Abstract][Full Text] [Related]
14. Heparin removal after cardiopulmonary bypass in a patient with adverse reaction to protamine.
Tevaearai HT; Jegger D; Mueller XM; Horisberger J; von Segesser LK
Thorac Cardiovasc Surg; 1998 Oct; 46(5):303-4. PubMed ID: 9885123
[TBL] [Abstract][Full Text] [Related]
15. Adverse events after protamine administration in patients undergoing cardiopulmonary bypass: risks and predictors of under-reporting.
Kimmel SE; Sekeres MA; Berlin JA; Goldberg LR; Strom BL
J Clin Epidemiol; 1998 Jan; 51(1):1-10. PubMed ID: 9467629
[TBL] [Abstract][Full Text] [Related]
16. Successful cardiopulmonary bypass in diabetics with anaphylactoid reactions to protamine.
Walker WS; Reid KG; Hider CF; Davidson IA; Boulton FE; Yap PL
Br Heart J; 1984 Jul; 52(1):112-4. PubMed ID: 6743419
[TBL] [Abstract][Full Text] [Related]
17. Case 3--2000. Improper administration of protamine during cardiopulmonary bypass.
Karaaslan D; Akpek EA; Sekerci S; Arslan G; Stammers A
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):327-9. PubMed ID: 10890491
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass.
Stafford-Smith M; Lefrak EA; Qazi AG; Welsby IJ; Barber L; Hoeft A; Dorenbaum A; Mathias J; Rochon JJ; Newman MF;
Anesthesiology; 2005 Aug; 103(2):229-40. PubMed ID: 16052104
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant and side-effects of protamine in cardiac surgery: a narrative review.
Boer C; Meesters MI; Veerhoek D; Vonk ABA
Br J Anaesth; 2018 May; 120(5):914-927. PubMed ID: 29661409
[TBL] [Abstract][Full Text] [Related]
20. The importance of aprotinin and pentoxifylline in preventing leukocyte sequestration and lung injury caused by protamine at the end of cardiopulmonary bypass surgery.
Ege T; Arar C; Canbaz S; Cikirikcioglu M; Sunar H; Yuksel V; Duran E
Thorac Cardiovasc Surg; 2004 Feb; 52(1):10-5. PubMed ID: 15002070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
